D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 28,662 288 World Ranking 11548 National Ranking 347

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Chemotherapy

His primary areas of investigation include Surgery, Internal medicine, Multiple myeloma, Transplantation and Chemotherapy. His Surgery study deals with Aspergillosis intersecting with Lung, Respiratory disease and Amphotericin B. Denis Caillot has researched Internal medicine in several fields, including Gastroenterology and Oncology.

His biological study spans a wide range of topics, including Hematopoietic stem cell transplantation and Pathology. In his research on the topic of Multiple myeloma, Survival analysis is strongly related with Urology. His studies deal with areas such as Myeloid leukemia and Maintenance therapy as well as Transplantation.

His most cited work include:

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis (2622 citations)
  • Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma (890 citations)
  • Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma (795 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Multiple myeloma, Surgery, Oncology and Transplantation. Denis Caillot works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Immunology. His Multiple myeloma research is multidisciplinary, incorporating perspectives in Newly diagnosed and Dexamethasone.

He works mostly in the field of Surgery, limiting it down to concerns involving Aspergillosis and, occasionally, Mycosis. His study looks at the relationship between Oncology and fields such as Myeloid leukemia, as well as how they intersect with chemical problems. His Transplantation study combines topics in areas such as Retrospective cohort study and Bone marrow, Minimal residual disease.

He most often published in these fields:

  • Internal medicine (65.96%)
  • Multiple myeloma (43.07%)
  • Surgery (33.73%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (65.96%)
  • Oncology (32.53%)
  • Multiple myeloma (43.07%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Oncology, Multiple myeloma, Newly diagnosed and Dexamethasone are his primary areas of study. His research on Internal medicine often connects related areas such as Stem cell. His work deals with themes such as Hematopoietic stem cell transplantation, Cyclophosphamide, Chemotherapy, Myeloid leukemia and Hazard ratio, which intersect with Oncology.

Many of his research projects under Multiple myeloma are closely connected to In patient with In patient, tying the diverse disciplines of science together. His Autologous stem-cell transplantation research also works with subjects such as

  • Extramedullary disease which connect with Novel agents,
  • Incidence, which have a strong connection to Transplantation Conditioning, Surgery, Malignancy and Salvage therapy. His Transplantation research incorporates elements of Cumulative incidence and Lymphoma.

Between 2017 and 2021, his most popular works were:

  • Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study (261 citations)
  • Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study (136 citations)
  • Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial (83 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Chemotherapy

Denis Caillot mainly investigates Internal medicine, Multiple myeloma, Oncology, Transplantation and Thalidomide. His Internal medicine study frequently draws connections to other fields, such as Gastroenterology. His research in the fields of Bortezomib, Lenalidomide and Autologous stem-cell transplantation overlaps with other disciplines such as In patient and Text mining.

His work in Oncology tackles topics such as Gemtuzumab ozogamicin which are related to areas like Chemotherapy regimen. His studies in Transplantation integrate themes in fields like Positron emission tomography, Newly diagnosed, Standard technique and Blood pool. His Pomalidomide study in the realm of Thalidomide connects with subjects such as Standard treatment.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)

3478 Citations

Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

Michel Attal;Jean-Luc Harousseau;Thierry Facon;François Guilhot.
The New England Journal of Medicine (2003)

1414 Citations

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Michel Attal;Valerie Lauwers-Cances;Gerald Marit;Denis Caillot.
The New England Journal of Medicine (2012)

1157 Citations

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Hervé Avet-Loiseau;Michel Attal;Philippe Moreau;Catherine Charbonnel.
Blood (2007)

1063 Citations

Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot.
Clinical Infectious Diseases (2002)

1029 Citations

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

Denis Caillot;Olivier Casasnovas;Alain Bernard;Jean-Francois Couaillier.
Journal of Clinical Oncology (1997)

990 Citations

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

Michel Attal;Jean-Luc Harousseau;Serge Leyvraz;Chantal Doyen.
Blood (2006)

860 Citations

Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia

Denis Caillot;Jean-Francois Couaillier;Alain Bernard;Olivier Casasnovas.
Journal of Clinical Oncology (2001)

745 Citations

Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

Jean-Luc Harousseau;Michel Attal;Hervé Avet-Loiseau;Gerald Marit.
Journal of Clinical Oncology (2010)

697 Citations

Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

Philippe Moreau;Thierry Facon;Michel Attal;Cyrille Hulin.
Blood (2002)

694 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Denis Caillot

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 217

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 180

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 172

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 167

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 163

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 154

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 150

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 147

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 136

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 129

Martha Q. Lacy

Martha Q. Lacy

Mayo Clinic

Publications: 128

Michele Cavo

Michele Cavo

University of Bologna

Publications: 127

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 122

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 112

Hervé Avet-Loiseau

Hervé Avet-Loiseau

Inserm : Institut national de la santé et de la recherche médicale

Publications: 104

Francis K. Buadi

Francis K. Buadi

Mayo Clinic

Publications: 102

Trending Scientists

Upkar Varshney

Upkar Varshney

Georgia State University

Klaus Doppler

Klaus Doppler

Nokia (United States)

Ronnie Belmans

Ronnie Belmans

KU Leuven

Kamran Oveyssi

Kamran Oveyssi

Western Digital (Japan)

Zhenyi Zhang

Zhenyi Zhang

State Ethnic Affairs Commission

Niranjan Karak

Niranjan Karak

Tezpur University

Guido Lingua

Guido Lingua

University of Eastern Piedmont Amadeo Avogadro

S. Stoney Simons

S. Stoney Simons

National Institutes of Health

Guy Serre

Guy Serre

Federal University of Toulouse Midi-Pyrénées

John A. Ellis

John A. Ellis

Western University of Health Sciences

Robert L. Goldstone

Robert L. Goldstone

Indiana University

Linda L. Chao

Linda L. Chao

University of California, San Francisco

Giampaolo Tortora

Giampaolo Tortora

University of Verona

Thomas M. Mack

Thomas M. Mack

University of Southern California

Franco Mandelli

Franco Mandelli

Sapienza University of Rome

Michael Mandelbaum

Michael Mandelbaum

Johns Hopkins University

Something went wrong. Please try again later.